Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’

By Öztiryaki Ahmet H.   Soares-da-Silva Patricio  

Pharmaceuticals, Vol. 3, Iss. 12, 2010-12 ,pp. : 3629-3632

MDPI

Access to resources Recommend Favorite

Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and the Role of Therapeutic Drug Monitoring for Management

By Rathbun R. Chris   Liedtke Michelle D.  

Pharmaceutics, Vol. 3, Iss. 4, 2011-10 ,pp. : 745-781

MDPI

Access to resources Recommend Favorite

Overview of Nrf2 as Therapeutic Target in Epilepsy

By Carmona-Aparicio Liliana   Pérez-Cruz Claudia   Zavala-Tecuapetla Cecilia   Granados-Rojas Leticia   Rivera-Espinosa Liliana   Montesinos-Correa Hortencia   Hernández-Damián Jacqueline   Pedraza-Chaverri José   Sampieri Aristides III   Coballase-Urrutia Elvia   Cárdenas-Rodríguez Noemí  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 18348-18367

MDPI

Access to resources Recommend Favorite

Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update

By Mohn Emily S.   Kern Hua J.   Saltzman Edward   Mitmesser Susan H.   McKay Diane L.  

Pharmaceutics, Vol. 10, Iss. 1, 2018-03 ,pp. : 36-36

MDPI

Access to resources Recommend Favorite

The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis

By Yu Megan   Tsai Sheng-Feng   Kuo Yu-Min  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1260-1260

MDPI

Access to resources Recommend Favorite